AsOf

Recorded or changed on this day 2026-11-08

2,251–2,300 of 46,540 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 525,000,000 United States dollar
Amgen quarterly operating income: 525,000,000 United States dollar, claim clm_8E08DF4BFFD6 · ended · superseded by clm_148D97D70B0C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,358,000,000 United States dollar
Amgen cash and equivalents: 3,358,000,000 United States dollar, claim clm_8E4F00DBED65 · ended · superseded by clm_88AF69313798 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,445,000,000 United States dollar
Amgen cash and equivalents: 9,445,000,000 United States dollar, claim clm_8E5607E4B59B · ended · superseded by clm_F9355A194FAC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 23,362,000,000 United States dollar
Amgen revenue: 23,362,000,000 United States dollar, claim clm_8EF1DBCB836F · ended · superseded by clm_2B6D201D77C0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,666,000,000 United States dollar
Amgen quarterly operating income: 2,666,000,000 United States dollar, claim clm_8FA61AE28EA3 · ended · superseded by clm_DBECC41209EA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 75,116,000,000 United States dollar
Amgen total assets: 75,116,000,000 United States dollar, claim clm_9006A4E3AEA7 · ended · superseded by clm_D40F2EB93762 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 24,382,000,000 United States dollar
Amgen total equity: 24,382,000,000 United States dollar, claim clm_905DE244F62B · ended · superseded by clm_7580FDD62A85 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 9,139,000,000 United States dollar
Amgen operating income: 9,139,000,000 United States dollar, claim clm_926C65AE4F09 · ended · superseded by clm_018B07550FF4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,019,000,000 United States dollar
Amgen quarterly net income: 1,019,000,000 United States dollar, claim clm_928390BED923 · ended · superseded by clm_1D9A473B7296 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · operating income · 9,080,000,000 United States dollar
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · quarterly net income · 3,864,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 27,967,000,000 United States dollar
Amgen total equity: 27,967,000,000 United States dollar, claim clm_92CB2B598E88 · ended · superseded by clm_94F707C99E20 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,986,000,000 United States dollar
Amgen quarterly revenue: 6,986,000,000 United States dollar, claim clm_92E3CC76739F · ended · superseded by clm_DC8081A3AB65 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · fiscal year end · 12-31
Amgen fiscal year end: 12-31, claim clm_932BE2EE8880 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 12,038,000,000 United States dollar
Amgen cash and equivalents: 12,038,000,000 United States dollar, claim clm_93389ECFE0A1 · ended · superseded by clm_89D0D620B239 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 760,670,000 shares
Amgen shares outstanding: 760,670,000 shares, claim clm_93F41910F022 · ended · superseded by clm_03C8CF5E3CB4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,902,000,000 United States dollar
Amgen quarterly operating income: 1,902,000,000 United States dollar, claim clm_941927EE0CBF · ended · superseded by clm_F42B8D164D66 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 7,629,000,000 United States dollar
Amgen cash and equivalents: 7,629,000,000 United States dollar, claim clm_9441264854A2 · ended · superseded by clm_0B4F8228696C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 28,083,000,000 United States dollar
Amgen total equity: 28,083,000,000 United States dollar, claim clm_94F707C99E20 · ended · superseded by clm_F89E040E0B16 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,485,000,000 United States dollar
Amgen cash and equivalents: 3,485,000,000 United States dollar, claim clm_950B1AD7EAC9 · ended · superseded by clm_E62A544C9923 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 40,940,000,000 United States dollar
Amgen total assets: 40,940,000,000 United States dollar, claim clm_960D1E6B27F0 · ended · superseded by clm_FD45F1550892 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 752,091,038 shares
Amgen shares outstanding: 752,091,038 shares, claim clm_9623B7B662B5 · ended · superseded by clm_DACE114B6A42 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 720,562,246 shares
Amgen shares outstanding: 720,562,246 shares, claim clm_96402624AA53 · ended · superseded by clm_185AD84BC290 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,378,000,000 United States dollar
Amgen quarterly operating income: 2,378,000,000 United States dollar, claim clm_971916A525E3 · ended · superseded by clm_5EAB20C5AA2A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,527,000,000 United States dollar
Amgen quarterly revenue: 5,527,000,000 United States dollar, claim clm_9742AA3344DF · ended · superseded by clm_293E3106D6E2 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · quarterly revenue · 10,365,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 30,773,000,000 United States dollar
Amgen total equity: 30,773,000,000 United States dollar, claim clm_99201951EE61 · ended · superseded by clm_BF0D3030F73E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,339,000,000 United States dollar
Amgen quarterly operating income: 2,339,000,000 United States dollar, claim clm_9938617951E0 · ended · superseded by clm_CB3F23126391 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,167,000,000 United States dollar
Amgen quarterly net income: 1,167,000,000 United States dollar, claim clm_9969F416755C · ended · superseded by clm_5A82BDA9230D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,803,000,000 United States dollar
Amgen quarterly net income: 1,803,000,000 United States dollar, claim clm_99BF980BB9EA · ended · superseded by clm_733FEFB5E7FA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,557,000,000 United States dollar
Amgen quarterly revenue: 5,557,000,000 United States dollar, claim clm_9AD858C121AE · ended · superseded by clm_0261B36A9FD9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 9,794,000,000 United States dollar
Amgen operating income: 9,794,000,000 United States dollar, claim clm_9C393580212E · ended · superseded by clm_3FE1CD809E20 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,726,000,000 United States dollar
Amgen quarterly operating income: 2,726,000,000 United States dollar, claim clm_9C5726C18879 · ended · superseded by clm_2D8C36C0626B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,901,000,000 United States dollar
Amgen quarterly revenue: 5,901,000,000 United States dollar, claim clm_9E8DA72630EB · ended · superseded by clm_C2407B4C4D35 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 748,360,906 shares
Amgen shares outstanding: 748,360,906 shares, claim clm_9F5464384718 · ended · superseded by clm_632362E81884 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 62,539,000,000 United States dollar
Amgen total assets: 62,539,000,000 United States dollar, claim clm_9F85DA6C69DF · ended · superseded by clm_627ADC7F9C5A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,483,000,000 United States dollar
Amgen quarterly operating income: 1,483,000,000 United States dollar, claim clm_A00D04DA0A77 · ended · superseded by clm_6609F02715B5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 66,125,000,000 United States dollar
Amgen total assets: 66,125,000,000 United States dollar, claim clm_A0287B4C76BE · ended · superseded by clm_1DC4233C61D6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,244,000,000 United States dollar
Amgen quarterly net income: 1,244,000,000 United States dollar, claim clm_A1443987DC93 · ended · superseded by clm_0A7CF5308206 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 40,366,000,000 United States dollar
Amgen total assets: 40,366,000,000 United States dollar, claim clm_A1DE406B5E7E · ended · superseded by clm_E2811DD805A8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 52,226,000,000 United States dollar
Amgen total assets: 52,226,000,000 United States dollar, claim clm_A28B5FEC066F · ended · superseded by clm_ED89BA9D10C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 10,659,000,000 United States dollar
Amgen total equity: 10,659,000,000 United States dollar, claim clm_A29CDA8096D2 · ended · superseded by clm_F743BC59372A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 538,361,851 shares
Amgen shares outstanding: 538,361,851 shares, claim clm_A337751C1DB4 · ended · superseded by clm_2EA05ED8BE57 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 4,627,000,000 United States dollar
Amgen net income: 4,627,000,000 United States dollar, claim clm_A36EA59B9520 · ended · superseded by clm_77675AD86D11 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 90,141,000,000 United States dollar
Amgen total assets: 90,141,000,000 United States dollar, claim clm_A3A1C9D984F8 · ended · superseded by clm_D061D89A7312 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 1,012,138,434 shares
Amgen shares outstanding: 1,012,138,434 shares, claim clm_A4143E50C193 · ended · superseded by clm_4C0262AA6F8C · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · country · United States
Amgen country: United States, claim clm_A41E744C9D9B · valid · 3 sources · conf 0.70
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 7,527,000,000 United States dollar
Amgen total equity: 7,527,000,000 United States dollar, claim clm_A4EA1DDC1704 · ended · superseded by clm_636768003464 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 77,862,000,000 United States dollar
Amgen total assets: 77,862,000,000 United States dollar, claim clm_A52F1A8099CB · ended · superseded by clm_174E9062ADCC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 11,969,000,000 United States dollar
Amgen cash and equivalents: 11,969,000,000 United States dollar, claim clm_A5791D18E55A · ended · superseded by clm_65015952E899 · 1 source (1 primary) · conf 0.95

What the statuses mean